Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ASCO Direct Highlights Miami Symposium 2019 /
Important developments in radiation oncology

12th - 13th Jul 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.07.19
Views: 1449

Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA

Dr Ana Botero speaks to ecancer at the 2019 ASCO Direct Highlights Symposium in Miami about the radiation oncology highlights from this year's meeting.

She begins by describing the NSABP-39 study, which looked at the effects of partial breast radiation therapy compared to whole breast radiation therapy in patients with early-stage breast cancer.

Dr Botero also discusses another study which compared transoral robotic surgery (TORS) to combined chemoradiation therapy in patients with squamous cell carcinoma.

Moving onto locally advanced lung cancer, she also describes a study which evaluated the incorporation of checkpoint inhibitors with chemoradiation therapy - which so far is displaying some benefit in the local control of the disease.

Lastly, Dr Botero discusses the use of whole-brain radiation and stereotaxic radiation therapy to treat brain metastases.


Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation